Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidetoshi Shiga

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 12, 2002
Continuous hemofiltration/hemodiafiltration in critical careShigeto Oda, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.
Critical Care Medicine|October 16, 2004
Partial liquid ventilation with FC-77 suppresses the release of lipid mediators in rat acute lung injury modelYoh Hirayama, Hiroyuki Hirasawa, Shigeto Oda, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 4, 2005
Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilterShigeto Oda, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.
Nihon Geka Gakkai Zasshi|July 30, 2003
[Humoral mediators in the pathophysiology of organ dysfunction in sepsis]Shigeto Oda, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 2, 2009
Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failureTakehito Yokoi, Shigeto Oda, Hidetoshi Shiga, et al.
The Journal of Trauma|December 31, 2005
Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complicationsEizo Watanabe, Hiroyuki Hirasawa, Shigeto Oda, et al.
Blood Purification|December 8, 2004
Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro studyShigeto Oda, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.
Blood Purification|March 27, 2004
Modulation of polymorphonuclear leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltrationTakeshi Hirano, Hiroyuki Hirasawa, Shigeto Oda, et al.
Blood Purification|December 23, 2014
Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary reportHidetoshi Shiga, Hiroyuki Hirasawa, Osamu Nishida, et al.
Blood Purification|August 19, 2004
Catheter-related infections in continuous hemodiafiltration in intensive care patientsTaka-aki Nakada, Hiroyuki Hirasawa, Shigeto Oda, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 12, 2002
Continuous hemofiltration/hemodiafiltration in critical careShigeto Oda, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.
Critical Care Medicine|October 16, 2004
Partial liquid ventilation with FC-77 suppresses the release of lipid mediators in rat acute lung injury modelYoh Hirayama, Hiroyuki Hirasawa, Shigeto Oda, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 4, 2005
Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilterShigeto Oda, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.
Nihon Geka Gakkai Zasshi|July 30, 2003
[Humoral mediators in the pathophysiology of organ dysfunction in sepsis]Shigeto Oda, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 2, 2009
Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failureTakehito Yokoi, Shigeto Oda, Hidetoshi Shiga, et al.
The Journal of Trauma|December 31, 2005
Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complicationsEizo Watanabe, Hiroyuki Hirasawa, Shigeto Oda, et al.
Blood Purification|December 8, 2004
Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro studyShigeto Oda, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.
Blood Purification|March 27, 2004
Modulation of polymorphonuclear leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltrationTakeshi Hirano, Hiroyuki Hirasawa, Shigeto Oda, et al.
Blood Purification|December 23, 2014
Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary reportHidetoshi Shiga, Hiroyuki Hirasawa, Osamu Nishida, et al.
Blood Purification|August 19, 2004
Catheter-related infections in continuous hemodiafiltration in intensive care patientsTaka-aki Nakada, Hiroyuki Hirasawa, Shigeto Oda, et al.
Pageof 3